Department of Dermatology, University of Trieste, Trieste, Italy.
Department of Medical Oncology, Centro di Riferimento Oncologico di Aviano IRCCS, Istituto di ricovero e cura a carattere scientifico, Aviano, Italy.
J Dermatol. 2024 May;51(5):714-718. doi: 10.1111/1346-8138.17075. Epub 2024 Jan 13.
The dermoscopic diagnosis of amelanotic/hypomelanotic lentigo maligna/lentigo maligna melanoma (AHLM/LMM) may be very difficult in its early stages because of lack of pigment. Reflectance confocal microscopy (RCM) is an imaging technique that is especially helpful for the diagnosis of lentigo maligna. To determine the diagnostic performances of dermoscopy and RCM in the diagnosis of AHLM/LMMs we evaluated dermoscopic and RCM images of consecutive cases of histopathologically confirmed AHLM/LMMs, amelanotic/hypomelanotic basal cell carcinoma and squamous cell carcinoma (AHBCCs/AHSCCs), amelanotic/hypomelanotic benign lesions (AHBLs), and actinic keratoses (AKs) from five participating centers. Sensitivity, specificity, accuracy, predictive values, and level of diagnosis confidence were calculated for both diagnostic procedures. Both dermoscopy and RCM showed diagnostic performance >97% in the diagnosis of AHLM/LMMs versus AHBCC/AHSCCs and their combination slightly improved diagnostic performance, with accuracy increasing from 98.0% to 99.1%. Similarly, RCM in combination with dermoscopy showed a tiny increase in the diagnostic performance in the diagnosis of AHLM/LMMs versus AHBLs (accuracy increased from 87.2% to 88.8%) and versus AKs (accuracy increased from 91.4% to 93.4%). Although the increase in diagnostic performance due to RCM was modest, the combination of dermoscopy and RCM greatly increased the level of confidence; high confidence in the diagnosis of AHLM/LMMs versus AHBLs increased from 36.2% with dermoscopy alone to 76.6% with dermoscopy plus RMC. Based on our results, dermoscopy and RCM should be complementary to improve not only diagnostic accuracy but also the level of diagnostic certainty in the diagnosis of AHLM/LMMs.
无色素性/低色素性恶性雀斑样痣/恶性黑素瘤(AHLM/LMM)在早期阶段由于缺乏色素,其皮肤镜诊断可能非常困难。反射共聚焦显微镜(RCM)是一种成像技术,特别有助于恶性雀斑样痣的诊断。为了确定皮肤镜和 RCM 在 AHLM/LMM 诊断中的诊断性能,我们评估了来自五个参与中心的经组织病理学证实的 AHLM/LMM、无色素性/低色素性基底细胞癌和鳞状细胞癌(AHBCC/AHSCC)、无色素性/低色素性良性病变(AHBL)和光化性角化病(AK)的连续病例的皮肤镜和 RCM 图像。计算了两种诊断方法的敏感性、特异性、准确性、预测值和诊断置信度水平。皮肤镜和 RCM 在诊断 AHLM/LMM 与 AHBCC/AHSCC 方面均表现出>97%的诊断性能,两者结合略微提高了诊断性能,准确性从 98.0%增加到 99.1%。同样,RCM 与皮肤镜结合在诊断 AHLM/LMM 与 AHBL 方面(准确性从 87.2%增加到 88.8%)和与 AK 方面(准确性从 91.4%增加到 93.4%)略微提高了诊断性能。尽管 RCM 增加的诊断性能适中,但皮肤镜和 RCM 的结合大大提高了诊断信心水平;与单独使用皮肤镜相比,对 AHLM/LMM 的诊断信心从 36.2%增加到了 76.6%。基于我们的结果,皮肤镜和 RCM 应互补使用,以提高 AHLM/LMM 的诊断准确性和诊断确定性水平。